Table 1 The clinicopathological relevance analysis of miR-98-5p and MAP4K4 expression in PDAC patients
From: Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4
Characteristic | miR-98-5p | MAP4K4 | ||||
|---|---|---|---|---|---|---|
| Â | Low | High | p value | Low | High | p value |
All cases | 25 | 27 | Â | 26 | 26 | Â |
Age | ||||||
  < 65 | 15 | 14 | 0.554 | 16 | 13 | 0.402 |
  ≥ 65 | 10 | 13 |  | 10 | 13 |  |
Gender | ||||||
 Male | 13 | 15 | 0.797 | 15 | 13 | 0.578 |
 Female | 12 | 12 |  | 11 | 13 |  |
CA199 | ||||||
  ≤ 100 | 9 | 15 | 0.158 | 15 | 9 | 0.095 |
  > 100 | 16 | 12 |  | 11 | 17 |  |
Tumor size | ||||||
  ≤ 2.5 cm | 8 | 20 | 0.002* | 19 | 9 | 0.005* |
  > 2.5 cm | 17 | 7 |  | 7 | 17 |  |
Differentiation grade | ||||||
 Well-moderately | 7 | 14 | 0.080 | 13 | 8 | 0.158 |
 Poorly | 18 | 13 |  | 13 | 18 |  |
TNM | ||||||
 I-IIA | 10 | 19 | 0.028* | 20 | 9 | 0.002* |
 IIB-IV | 15 | 8 |  | 6 | 17 |  |
Lymph node metastasis | ||||||
 Absence | 9 | 21 | 0.002* | 19 | 11 | 0.025* |
 Presence | 16 | 6 |  | 7 | 15 |  |
Blood vessel invasion | ||||||
 Absence | 10 | 18 | 0.054 | 17 | 11 | 0.095 |
 Presence | 15 | 9 |  | 9 | 15 |  |